Cite
HARVARD Citation
Ahamadi, M. et al. (2020). Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs. Clinical pharmacology & therapeutics. 107 (3), pp. 553-562. [Online].